Home/International Journal of Proteomics/Article Record
Peer-Reviewed Article September 27, 2011

Glycoproteomics-Based Identification of Cancer Biomarkers

Are you an author of this work?Link to your sovereign AfriScholar profile
Published in: International Journal of Proteomics
Publisher: Hindawi Publishing Corporation • Egypt • 2090-2166
DOI: https://doi.org/10.1155/2011/601937

Abstract

Protein glycosylation is one of the most common posttranslational modifications in mammalian cells. It is involved in many biological pathways and molecular functions and is well suited for proteomics-based disease investigations. Aberrant protein glycosylation may be associated with disease processes. Specific glycoforms of glycoproteins may serve as potential biomarkers for the early detection of disease or as biomarkers for the evaluation of therapeutic efficacy for treatment of cancer, diabetes, and other diseases. Recent technological developments, including lectin affinity chromatography and mass spectrometry, have provided researchers the ability to obtain detailed information concerning protein glycosylation. These in-depth investigations, including profiling and quantifying glycoprotein expression, as well as comprehensive glycan structural analyses may provide important information leading to the development of disease-related biomarkers. This paper describes methodologies for the detection of cancer-related glycoprotein and glycan structural alterations and briefly summarizes several current cancer-related findings.

Download Full Text PDFView at PublisherCrossref RecordCrossref XML

Verified Citation Velocity

Recorded scholarly citations in African and international peer-reviewed literature

63
Total Citations

Citations are continuously tracked and harvested across continental OJS endpoints and OpenAlex feeds.